Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-06-12 17:17 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
60,000 | |
Filed 2023-06-12 17:16 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
72,447 | |
Filed 2023-06-12 17:15 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
64,000 | |
Filed 2023-06-12 17:07 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
64,000 | |
Filed 2023-06-12 17:04 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
60,000 | |
Filed 2023-06-12 17:02 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
72,000 | |
Filed 2023-04-28 13:11 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,891
+5,500 vol $3.80 each |
133,386 | |
Filed 2023-04-28 13:11 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,498
+7,000 vol $3.79 each |
127,886 | |
Filed 2023-04-28 13:10 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,514
+5,500 vol $3.73 each |
120,886 | |
Filed 2023-04-28 13:10 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,023
+7,000 vol $3.72 each |
115,386 | |
Filed 2023-03-24 09:54 Tx date 2023-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,000 vol |
42,000 | |
Filed 2023-03-24 09:53 Tx date 2023-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-02-20 11:22 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Nelson, Jeffrey Edward
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,000 vol |
710,100 | |
Filed 2023-02-20 11:17 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,000 vol |
889,000 | |
Filed 2023-02-20 11:13 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+185,000 vol |
515,000 | |
Filed 2023-02-20 11:10 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+360,000 vol |
2,579,061 | |
Filed 2023-02-20 11:08 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,000 vol |
661,456 | |
Filed 2022-12-05 12:59 Tx date 2022-12-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,830
+7,000 vol $4.69 each |
10,000 | |
Filed 2022-12-05 09:32 Tx date 2022-12-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,580
+3,000 vol $4.86 each |
3,000 | |
Filed 2022-12-05 09:32 Tx date 2022-02-15 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-21 21:44 Tx date 2022-10-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,040
+4,000 vol $5.26 each |
4,000 | |
Filed 2022-10-21 21:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-21 21:42 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
10,000 | |
Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
9,400 | |
Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
9,000 | |
Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
8,955 | |
Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
6,300 | |
Filed 2022-10-21 21:40 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
6,195 | |
Filed 2022-10-21 21:39 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-21 21:38 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
||
Filed 2022-10-21 21:38 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
||
Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
||
Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
||
Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
||
Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
||
Filed 2022-10-21 12:02 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,013
+200 vol $5.07 each |
10,000 | |
Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,551
+300 vol $5.17 each |
9,800 | |
Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,876
+368 vol $5.10 each |
9,500 | |
Filed 2022-10-21 12:01 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,536
+300 vol $5.12 each |
9,132 | |
Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$516.00
+100 vol $5.16 each |
8,832 | |
Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,577
+700 vol $5.11 each |
8,732 | |
Filed 2022-10-21 12:00 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,006
+1,732 vol $5.20 each |
8,032 | |
Filed 2022-10-21 11:59 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,626
+700 vol $5.18 each |
6,300 | |
Filed 2022-10-21 11:59 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,344
+5,600 vol $5.24 each |
5,600 | |
Filed 2022-10-21 11:59 Tx date 2019-11-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
10,127 | |
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
9,527 | |
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
9,127 | |
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
9,082 | |
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
||
Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
6,427 | |
Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
||
Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
6,322 | |
Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+10,000 vol $5.00 each |
||
Filed 2022-10-21 10:49 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+10,000 vol $5.00 each |
||
Filed 2022-10-21 10:43 Tx date 2022-10-19 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$79,857
+15,000 vol $5.32 each |
15,000 | |
Filed 2022-10-19 16:21 Tx date 2022-10-19 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,918
+15,000 vol $4.93 each |
15,000 | |
Filed 2022-10-19 16:19 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-09-16 15:54 Tx date 2022-09-14 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+127 vol |
127 | |
Filed 2022-08-25 16:06 Tx date 2022-08-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Nelson, Jeffrey Edward
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
605,100 | ||
Filed 2022-06-01 14:39 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,000
+5,000 vol $5.60 each |
81,780 | |
Filed 2022-06-01 14:25 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,186
+822 vol $2.66 each |
76,780 | |
Filed 2022-06-01 14:24 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$35,279
+22,870 vol $1.54 each |
75,958 | |
Filed 2022-06-01 14:24 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$69,528
+45,072 vol $1.54 each |
53,088 | |
Filed 2022-06-01 14:23 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,954
+8,016 vol $1.12 each |
8,016 | |
Filed 2022-06-01 14:23 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,186.2734
-822 vol $2.66 each |
21,776 | |
Filed 2022-06-01 14:22 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-35,279.262
-22,870 vol $1.54 each |
22,598 | |
Filed 2022-06-01 14:21 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-69,528.0672
-45,072 vol $1.54 each |
45,468 | |
Filed 2022-06-01 14:21 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,954.6736
-8,016 vol $1.12 each |
90,540 | |
Filed 2022-03-24 10:35 Tx date 2022-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,219,061 | |
Filed 2022-03-24 10:33 Tx date 2022-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
556,456 | |
Filed 2022-03-24 10:29 Tx date 2022-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
759,000 | |
Filed 2022-02-16 20:53 Tx date 2022-02-15 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+330,000 vol |
330,000 | |
Filed 2022-02-16 20:51 Tx date 2022-02-15 |
$MIST
Milestone Pharmaceuticals Inc. |
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-29 12:01 Tx date 2021-03-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
396,456 | |
Filed 2021-03-29 12:00 Tx date 2021-03-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+240,000 vol |
584,000 | |
Filed 2021-03-29 11:58 Tx date 2021-03-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,000 vol |
474,146 | |
Filed 2021-03-29 11:53 Tx date 2021-03-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+670,000 vol |
1,719,061 | |
Filed 2020-12-07 14:02 Tx date 2019-12-30 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,616
+299 vol $15.44 each |
3,936,826 | |
Filed 2020-12-07 13:59 Tx date 2019-12-30 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,027
+1,034 vol $15.50 each |
3,936,527 | |
Filed 2020-11-02 11:07 Tx date 2019-12-30 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,621
+1,333 vol $15.47 each |
||
Filed 2020-11-02 11:14 Tx date 2020-03-19 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,806
+5,870 vol $10.87 each |
4,315,102 | |
Filed 2020-11-02 11:10 Tx date 2020-03-18 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,023
+2,705 vol $10.36 each |
4,309,232 | |
Filed 2020-11-02 11:09 Tx date 2020-03-02 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,483,083
+78,263 vol $18.95 each |
4,306,527 | |
Filed 2020-11-02 11:08 Tx date 2020-01-13 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,387,500
+270,000 vol $16.25 each |
4,228,264 | |
Filed 2020-11-02 11:08 Tx date 2019-12-31 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$332,289
+21,438 vol $15.50 each |
3,958,264 | |
Filed 2020-11-02 11:07 Tx date 2019-12-30 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,621
+1,333 vol $15.47 each |
3,936,826 | |
Filed 2020-11-02 11:06 Tx date 2019-11-30 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,400,000
+400,000 vol $16.00 each |
3,935,493 | |
Filed 2020-11-02 11:05 Tx date 2019-10-15 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,800
+1,100 vol $18.00 each |
3,535,493 | |
Filed 2020-11-02 11:05 Tx date 2019-10-11 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,798
+4,208 vol $17.30 each |
3,534,393 | |
Filed 2020-11-02 11:04 Tx date 2019-10-10 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,864
+179 vol $16.00 each |
3,530,185 | |
Filed 2020-11-02 11:03 Tx date 2019-10-03 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,935
+1,908 vol $18.31 each |
3,530,006 | |
Filed 2020-11-02 11:03 Tx date 2019-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110,046
+6,242 vol $17.63 each |
3,528,098 | |
Filed 2020-11-02 11:02 Tx date 2019-05-09 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000,005
+666,667 vol $15.00 each |
3,521,856 | |
Filed 2020-11-02 11:01 Tx date 2019-05-09 |
$MIST
Milestone Pharmaceuticals Inc. |
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,855,189 | ||
Filed 2020-10-02 17:20 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
30,000 | |
Filed 2020-10-02 17:20 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-02 17:18 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
30,000 | |
Filed 2020-10-02 17:17 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-27 10:48 Tx date 2020-08-26 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,778
+5,700 vol $1.54 each |
108,386 | |
Filed 2020-08-27 10:47 Tx date 2020-08-26 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,778
-5,700 vol $1.54 each |
196,456 | |
Filed 2020-07-30 14:25 Tx date 2020-07-29 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,555,000
-500,000 vol $11.11 each |
2,254,920 | |
Filed 2020-07-30 14:23 Tx date 2020-07-28 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-215,116.29
-19,863 vol $10.83 each |
2,754,920 | |
Filed 2020-06-08 16:34 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
202,156 | |
Filed 2020-06-08 16:33 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+18,043 vol |
102,686 | |
Filed 2020-06-08 16:32 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-27,786.22
-18,043 vol $1.54 each |
167,156 | |
Filed 2020-06-08 16:31 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+32,528 vol |
84,643 | |
Filed 2020-06-08 16:31 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-50,093.12
-32,528 vol $1.54 each |
185,199 | |
Filed 2020-06-08 16:30 Tx date 2019-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+2,500 vol |
52,115 | |
Filed 2020-06-08 16:29 Tx date 2019-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,850
-2,500 vol $1.54 each |
157,727 | |
Filed 2020-06-08 16:26 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
34,000 | |
Filed 2020-06-08 16:24 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
98,556 | |
Filed 2020-06-08 16:22 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
34,000 | |
Filed 2020-06-08 16:20 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
67,638 | |
Filed 2020-06-08 16:18 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
42,447 | |
Filed 2020-06-08 16:15 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
344,146 | |
Filed 2020-06-08 16:12 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+115,000 vol |
344,000 | |
Filed 2020-06-08 16:02 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,049,061 | |
Filed 2020-06-08 16:00 Tx date 2019-12-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+7,400 vol |
280,555 | |
Filed 2020-06-08 16:00 Tx date 2019-12-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,396
-7,400 vol $1.54 each |
699,061 | |
Filed 2020-01-28 21:17 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,000 vol |
309,146 | |
Filed 2020-01-28 21:16 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
220,227 | |
Filed 2020-01-28 21:15 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
906,461 | |
Filed 2020-01-28 21:14 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,000 vol |
229,000 | |
Filed 2020-01-28 07:50 Tx date 2020-01-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,361
+2,800 vol $21.20 each |
2,774,783 | |
Filed 2020-01-27 12:09 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
||
Filed 2020-01-27 12:08 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,000 vol |
||
Filed 2020-01-27 12:06 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
||
Filed 2020-01-27 12:04 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,000 vol |
||
Filed 2020-01-27 12:09 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
220,227 | |
Filed 2020-01-27 12:08 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,000 vol |
229,000 | |
Filed 2020-01-27 12:06 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
906,461 | |
Filed 2020-01-27 12:04 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,000 vol |
309,146 | |
Filed 2020-01-27 08:16 Tx date 2020-01-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$142,933
+6,949 vol $20.57 each |
2,771,983 | |
Filed 2020-01-23 14:01 Tx date 2020-01-22 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307,487
+15,161 vol $20.28 each |
2,765,034 | |
Filed 2020-01-22 10:17 Tx date 2020-01-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260,026
+13,703 vol $18.98 each |
2,749,873 | |
Filed 2020-01-22 10:16 Tx date 2020-01-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260,026
+13,703 vol $18.98 each |
||
Filed 2020-01-22 09:47 Tx date 2020-01-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260,026
+13,703 vol $18.98 each |
2,749,873 | |
Filed 2020-01-22 09:47 Tx date 2020-01-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260,026
+13,703 vol $18.98 each |
||
Filed 2020-01-21 14:38 Tx date 2020-01-17 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,029
+1,625 vol $18.48 each |
2,736,170 | |
Filed 2020-01-21 14:36 Tx date 2020-01-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$121,608
+6,600 vol $18.43 each |
2,734,545 | |
Filed 2020-01-21 14:33 Tx date 2020-01-17 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,029
+1,625 vol $18.48 each |
||
Filed 2020-01-21 14:32 Tx date 2020-01-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$121,608
+6,600 vol $18.43 each |
||
Filed 2020-01-21 13:47 Tx date 2020-01-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$121,608
+6,600 vol $18.43 each |
||
Filed 2020-01-21 13:47 Tx date 2020-01-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$121,608
+6,600 vol $18.43 each |
2,734,545 | |
Filed 2020-01-20 14:20 Tx date 2020-01-17 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,029
+1,625 vol $18.48 each |
||
Filed 2020-01-20 14:20 Tx date 2020-01-17 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,029
+1,625 vol $18.48 each |
2,729,570 | |
Filed 2020-01-16 09:10 Tx date 2020-01-15 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$127,528
+7,000 vol $18.22 each |
2,727,945 | |
Filed 2020-01-15 14:07 Tx date 2020-01-14 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,309
+635 vol $17.81 each |
2,720,945 | |
Filed 2019-11-15 14:55 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,000 vol |
83,556 | |
Filed 2019-11-15 14:51 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,000 vol |
19,000 | |
Filed 2019-11-15 14:46 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,000 vol |
19,000 | |
Filed 2019-11-15 14:40 Tx date 2019-11-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-09-12 09:21 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
104,596 | |
Filed 2019-09-12 09:15 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+147,000 vol |
147,000 | |
Filed 2019-09-12 09:13 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-24 13:53 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
52,638 | ||
Filed 2019-05-22 16:35 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-23 09:29 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
51,640 | ||
Filed 2019-05-23 09:27 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:52 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:52 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,516 | ||
Filed 2019-05-22 16:51 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:50 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
84,596 | ||
Filed 2019-05-22 16:49 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:46 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:45 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:44 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Kumar, Nilesh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:44 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Kumar, Nilesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:41 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Boorsma, Marco
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:41 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Boorsma, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:39 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
225,146 | ||
Filed 2019-05-22 16:39 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,456 | ||
Filed 2019-05-22 16:38 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
160,227 | ||
Filed 2019-05-22 16:37 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
49,615 | ||
Filed 2019-05-22 16:36 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
27,447 | ||
Filed 2019-05-22 16:36 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:35 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:34 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:34 Tx date 2019-04-10 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:34 Tx date 2019-04-10 |
$MIST
Milestone Pharmaceuticals Inc. |
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:33 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
706,461 | ||
Filed 2019-05-22 16:32 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
273,155 | ||
Filed 2019-05-22 16:31 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
79,556 | ||
Filed 2019-05-22 16:30 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:29 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
287,234 | ||
Filed 2019-05-22 16:28 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:24 Tx date 2017-03-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-22 16:21 Tx date 2017-03-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-17 08:35 Tx date 2019-05-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$8,753,326
+433,333 vol $20.20 each |
2,720,310 | |
Filed 2019-05-17 08:31 Tx date 2019-05-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,286,977 |